Collaboration will focus on developing exosome therapeutics for rare diseases More: University of Oxford links up with Evox Therapeutics Source: News
read moreNew analysis of prespecified subgroup comes from phase III THALES trial More: AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup Source: News
read moreInitial purchase includes 225 million doses of mRNA-based vaccine More: EU signs COVID-19 vaccine deal with CureVac Source: News
read moreCambrex looks to fill ‘onshore’ API manufacturing demand with $50M expansion in Iowa kblankenship Tue, 11/17/2020 – 10:56 More: Cambrex looks to fill 'onshore' API manufacturing demand with M expansion in Iowa Source: fierce
read moreBristol Myers’ hopes for a CAR-T nod by year-end fade as COVID-19 delays FDA inspection aliu Tue, 11/17/2020 – 10:31 More: Bristol Myers' hopes for a CAR-T nod by year-end fade as COVID-19 delays FDA inspection Source: fierce
read moreAlkermes flops FDA’s ‘remote review’ at manufacturing site for schizophrenia, bipolar disorder drug kblankenship Tue, 11/17/2020 – 09:52 More: Alkermes flops FDA's 'remote review' at manufacturing site for schizophrenia, bipolar disorder drug Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals